ArticleTranslational lung cancer research2021

Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.